Profile data is unavailable for this security.
About the company
Kyorin Pharmaceutical Co Ltd, formerly Kyorin Holdings Inc, is a Japan-based company mainly engaged in the pharmaceuticals business. The Pharmaceuticals segment is mainly engaged in the manufacture, purchase, sales and testing of pharmaceutical products, the purchase of raw materials for pharmaceuticals, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, the operations related to clinical trials and information gathering such as searching for drug discovery seeds, as well as the drug candidate compound discovery research and compound evaluation business. The Company also conducts the diagnostic businesses and verifies and creates research targets that are directly linked to drug discovery.
- Revenue in JPY (TTM)119.53bn
- Net income in JPY5.32bn
- Incorporated1958
- Employees2.14k
- LocationKyorin Pharmaceutical Co Ltd15/16F, Ochanomizu Sorashiti4-6, Kanda SurugadaiCHIYODA-KU 101-8311JapanJPN
- Phone+81 335254700
- Fax+81 335254780
- Websitehttps://www.kyorin-pharm.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Katakura Industries Co., Ltd. | 39.83bn | 3.01bn | 66.49bn | 1.04k | 20.77 | 0.8112 | 11.29 | 1.67 | 90.90 | 90.90 | 1,203.27 | 2,327.46 | 0.2858 | 2.35 | 4.49 | 38,300,000.00 | 2.29 | 2.35 | 2.99 | 3.34 | 38.30 | 37.75 | 8.01 | 8.32 | 2.58 | -- | 0.1097 | 18.81 | 16.62 | -2.04 | 8.09 | 18.87 | -7.46 | 10.76 |
| ispace Inc | 2.36bn | -2.37bn | 69.01bn | 216.00 | -- | 7.08 | -- | 29.28 | -31.36 | -31.36 | 29.06 | 104.64 | 0.1377 | 7.48 | 98.55 | -- | -13.83 | -- | -24.15 | -- | 39.38 | -- | -100.39 | -- | 2.05 | -- | 0.5623 | -- | 138.27 | -- | 79.24 | -- | -- | -- |
| ASKA Pharmaceutical Holdings Co Ltd | 62.84bn | 7.55bn | 69.81bn | 747.00 | 8.57 | 1.04 | 8.17 | 1.11 | 266.48 | 266.48 | 2,219.59 | 2,186.08 | 0.7066 | 1.69 | 4.08 | -- | 8.48 | 4.63 | 11.08 | 5.87 | 48.80 | 46.94 | 12.01 | 6.76 | 1.49 | -- | 0.1328 | 14.42 | 3.94 | 6.12 | 78.03 | 34.04 | -37.89 | 23.36 |
| JCR Pharmaceuticals Co Ltd | 42.87bn | 5.51bn | 82.48bn | 879.00 | 14.48 | 1.41 | 11.08 | 1.92 | 43.91 | 43.91 | 342.28 | 450.13 | 0.4349 | 0.5891 | 3.29 | -- | 5.62 | 8.66 | 8.47 | 13.46 | 72.90 | 74.51 | 12.92 | 18.24 | 1.22 | 27.69 | 0.2921 | 29.60 | 24.83 | 13.11 | 46.00 | 8.19 | 18.54 | 21.67 |
| Eiken Chemical Co Ltd | 40.05bn | 2.63bn | 82.71bn | 754.00 | 30.43 | 1.62 | 19.36 | 2.07 | 70.52 | 70.52 | 1,080.89 | 1,328.72 | 0.6262 | 2.83 | 3.40 | -- | 4.12 | 8.01 | 5.06 | 10.14 | 41.76 | 45.92 | 6.58 | 11.50 | 2.62 | -- | 0.0862 | 35.21 | -7.44 | 2.29 | -54.08 | -5.24 | 11.66 | 11.20 |
| Zeria Pharmaceutical Co Ltd | 75.73bn | 7.73bn | 106.29bn | 1.73k | 11.41 | 1.11 | 7.93 | 1.40 | 175.39 | 175.39 | 1,717.90 | 1,806.33 | 0.5304 | 1.48 | 3.99 | -- | 5.39 | 3.89 | 8.39 | 6.28 | 73.29 | 71.93 | 10.16 | 7.57 | 0.7946 | 13.04 | 0.3667 | 35.00 | 10.74 | 4.14 | 24.78 | 17.49 | 20.77 | 5.29 |
| Kyorin Pharmaceutical Co Ltd | 119.53bn | 5.32bn | 110.80bn | 2.14k | 18.50 | 0.7533 | 12.96 | 0.927 | 92.70 | 92.70 | 2,082.82 | 2,276.51 | 0.6759 | 1.34 | 2.61 | -- | 3.01 | 3.05 | 3.90 | 3.79 | 43.01 | 47.11 | 4.45 | 4.76 | 1.45 | -- | 0.138 | 66.81 | 5.53 | 1.02 | 12.68 | -4.98 | 7.41 | -7.06 |
| Torii Pharmaceutical Co Ltd | 56.28bn | 5.29bn | 110.88bn | 583.00 | 20.47 | 0.909 | 19.30 | 1.97 | 188.05 | 188.05 | 2,002.44 | 4,235.56 | 0.4288 | 2.72 | 2.25 | 96,531,740.00 | 4.03 | 6.52 | 4.44 | 7.35 | 44.83 | 49.55 | 9.40 | 17.98 | 5.58 | -- | 0.00 | 24.17 | 11.74 | -2.67 | 4.44 | 28.76 | -20.38 | 20.11 |
| Mochida Pharmaceutical Co Ltd | 102.89bn | 4.55bn | 114.10bn | 1.53k | 24.10 | 0.8436 | 17.55 | 1.11 | 126.33 | 126.33 | 2,868.81 | 3,609.64 | 0.6478 | 1.86 | 3.28 | -- | 2.86 | 4.37 | 3.44 | 5.31 | 50.61 | 52.47 | 4.42 | 6.71 | 3.31 | -- | -- | 44.88 | -0.3641 | -1.26 | -31.61 | -11.63 | 10.91 | -1.21 |
| GNI Group Ltd | 27.75bn | 9.55bn | 117.10bn | 843.00 | 12.48 | 3.38 | 9.87 | 4.22 | 188.10 | 188.10 | 554.62 | 693.41 | 0.5569 | 2.01 | 7.89 | 32,921,710.00 | 22.45 | 7.23 | 26.73 | 8.80 | 84.78 | 85.75 | 40.32 | 14.57 | 2.74 | 30.59 | 0.1417 | 0.00 | 49.32 | 38.97 | 1,981.71 | -- | 19.69 | -- |
| Takara Bio Inc | 43.51bn | 1.48bn | 130.41bn | 1.79k | 88.11 | 1.17 | 20.28 | 3.00 | 12.29 | 12.29 | 361.29 | 926.00 | 0.3474 | 1.45 | 3.71 | -- | 1.21 | 10.06 | 1.32 | 11.38 | 61.85 | 64.39 | 3.47 | 18.84 | 7.10 | -- | 0.0086 | 27.55 | -44.33 | 3.95 | -90.76 | -16.55 | 16.18 | 19.42 |
| Nxera Pharma Co Ltd | 16.43bn | -9.07bn | 132.16bn | 350.00 | -- | 2.00 | -- | 8.04 | -107.30 | -107.30 | 194.96 | 736.60 | 0.1309 | -- | 5.77 | 46,954,280.00 | -7.23 | -0.6588 | -7.78 | -0.7036 | 74.44 | 89.83 | -55.20 | -4.46 | 4.03 | -10.91 | 0.5238 | -- | -18.00 | -- | -1,982.98 | -- | -- | -- |
| Sumitomo Pharma Co Ltd | 314.56bn | -314.97bn | 134.89bn | 6.25k | -- | 0.863 | -- | 0.4288 | -792.79 | -792.79 | 791.76 | 392.82 | 0.308 | 1.21 | 3.76 | -- | -30.84 | -5.07 | -54.58 | -7.73 | 59.76 | 69.99 | -100.12 | -12.28 | 0.2992 | -- | 0.7285 | -- | -43.38 | -7.29 | -322.71 | -- | 4.02 | -- |
| Towa Pharmaceutical Co Ltd | 227.93bn | 16.17bn | 140.64bn | 4.30k | 8.31 | 0.8619 | 5.69 | 0.617 | 328.58 | 328.58 | 4,630.88 | 3,167.26 | 0.5684 | 1.51 | 3.66 | -- | 4.03 | 4.21 | 5.03 | 5.63 | 35.70 | 39.23 | 7.10 | 7.23 | 1.46 | -- | 0.5649 | 20.79 | 9.13 | 16.74 | 634.80 | 3.72 | 28.20 | 10.86 |
| Kissei Pharmaceutical Co Ltd | 75.58bn | 11.16bn | 155.82bn | 1.80k | 12.82 | 0.6349 | 10.02 | 2.06 | 246.57 | 246.57 | 1,669.95 | 4,977.43 | 0.3135 | 1.56 | 2.94 | -- | 4.68 | 3.61 | 5.05 | 3.90 | 49.41 | 49.47 | 14.94 | 12.69 | 4.43 | -- | 0.006 | 34.69 | 11.98 | 0.8919 | 6.00 | 15.28 | 6.58 | 10.40 |
| KAKEN PHARMACEUTICAL CO., LTD. | 72.04bn | 8.03bn | 158.03bn | 1.13k | 16.17 | 0.9062 | 18.05 | 2.19 | 212.76 | 212.76 | 1,909.11 | 3,796.04 | 0.4264 | 2.05 | 3.37 | -- | 4.75 | 6.83 | 5.40 | 7.87 | 53.49 | 54.78 | 11.14 | 14.48 | 4.72 | -- | 0.0261 | 51.19 | -1.29 | -5.21 | 47.52 | -14.70 | 0.3639 | 0.00 |
Data as of May 21 2024. Currency figures normalised to Kyorin Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
18.51%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Kopernik Global Investors LLCas of 15 Jun 2023 | 4.03m | 6.23% |
| The Vanguard Group, Inc.as of 09 May 2024 | 1.65m | 2.56% |
| Amundi Japan Ltd.as of 16 May 2024 | 1.45m | 2.24% |
| Nomura Asset Management Co., Ltd.as of 30 Apr 2024 | 1.35m | 2.10% |
| BlackRock Fund Advisorsas of 09 May 2024 | 767.70k | 1.19% |
| Nikko Asset Management Co., Ltd.as of 10 May 2024 | 643.00k | 1.00% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 635.14k | 0.98% |
| Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 607.10k | 0.94% |
| Janus Henderson Investors (Singapore) Ltd.as of 31 Mar 2024 | 474.20k | 0.73% |
| Sompo Asset Management Co. Ltd.as of 02 Nov 2022 | 347.90k | 0.54% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
